BeOne Medicines Financial Overview
BeOne Medicines's market cap is currently $38.33B. The company's EPS TTM is $1.09; its P/E ratio is 600.85; BeOne Medicines is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $1.50. See an overview of income statement, balance sheet, and cash flow financials.
